Episode Details
Back to Episodes
Dr. Robert J. McCunney on The Aging Code: Longevity, Gene Therapy, Biohacking, and the Science of Living Longer
Published 1 week, 3 days ago
Description
In this episode of The Neil Haley Show, Neil “The Media Giant” Haley welcomes physician, scientist, and author Dr. Robert J. McCunney to discuss his medical thriller The Aging Code and the real science behind one of humanity’s oldest questions: Can we slow down—or even reverse—the aging process?
Dr. McCunney explains that the premise may sound futuristic, but serious researchers are already studying ways to extend lifespan using approaches involving genetics, medications, peptides, stem cells, and other emerging technologies.
Much of the research remains in animals, but the results are intriguing enough to raise major scientific questions.
Before writing The Aging Code, McCunney focused his research on three primary subjects: aging, gene therapy, and the Russia-Ukraine conflict. He then built fictional characters around those themes, including a health journalist investigating longevity research, a physician encountering unusual cases of accelerated aging, and a Russian genetic scientist.
The science, however, is grounded in research.
One of the most fascinating examples is progeria, a rare genetic disorder associated with dramatically accelerated aging. McCunney explains that if a genetic mutation can accelerate aging, researchers naturally wonder whether genetic interventions could potentially slow it down.
That leads to topics such as CRISPR, telomeres, gene therapy, stem cells, and longevity-related proteins.
Neil and Dr. McCunney also discuss rapamycin, a medication originally used to suppress the immune system in transplant patients. Animal studies have examined whether it may extend lifespan, but McCunney stresses that results in mice do not automatically translate to humans.
That distinction becomes one of the episode’s biggest lessons.
Promising science is not the same thing as proven medicine.
McCunney explains that dosage, frequency, toxicity, long-term side effects, and the length of follow-up all matter. Something that appears successful in an animal model may behave very differently in a human being.
That concern also applies to biohacking.
Neil brings up well-known longevity personalities who experiment aggressively with diet, supplements, technology, testing, and other interventions. McCunney says the fundamental problem with experimenting on yourself is that you may not know whether something is effective, how much is safe, or what unintended consequences could appear years later.
The conversation then moves into longevity centers, which combine traditional preventive medicine with emerging interventions intended to improve healthspan and potentially extend life.
Some begin with established practices: cancer screenings, exercise, nutrition, weight management, and monitoring known risk factors.
Others push further into experimental territory involving stem cells, gene therapies, and off-label medications.
McCunney also explains an important difference between life expectancy and lifespan.
Life expectancy is a statistical average influenced by deaths from accidents, disease, childhood mortality, and countless other factors. Lifespan asks a different question: how long can a human being potentially live?
That distinction matters as more people live into their 90s and beyond.
McCunney says basic habits still matter tremendously: remaining physically active, staying socially connected, keeping the mind engaged, eating well, maintaining a healthy weight, and avoiding smoking. Genetics may become increasingly important among people who reach exceptionally advanced ages.
The discussion also touches on brain health, Alzheimer’s disease, AI, Neuralink, robotics, and whether future technology could eventually redefine what it means to grow old.
McCunney does not claim that humans are about to become immortal. His approach is more measured: the science is advancing quickly enough that ideas once dismissed as impossible
Dr. McCunney explains that the premise may sound futuristic, but serious researchers are already studying ways to extend lifespan using approaches involving genetics, medications, peptides, stem cells, and other emerging technologies.
Much of the research remains in animals, but the results are intriguing enough to raise major scientific questions.
Before writing The Aging Code, McCunney focused his research on three primary subjects: aging, gene therapy, and the Russia-Ukraine conflict. He then built fictional characters around those themes, including a health journalist investigating longevity research, a physician encountering unusual cases of accelerated aging, and a Russian genetic scientist.
The science, however, is grounded in research.
One of the most fascinating examples is progeria, a rare genetic disorder associated with dramatically accelerated aging. McCunney explains that if a genetic mutation can accelerate aging, researchers naturally wonder whether genetic interventions could potentially slow it down.
That leads to topics such as CRISPR, telomeres, gene therapy, stem cells, and longevity-related proteins.
Neil and Dr. McCunney also discuss rapamycin, a medication originally used to suppress the immune system in transplant patients. Animal studies have examined whether it may extend lifespan, but McCunney stresses that results in mice do not automatically translate to humans.
That distinction becomes one of the episode’s biggest lessons.
Promising science is not the same thing as proven medicine.
McCunney explains that dosage, frequency, toxicity, long-term side effects, and the length of follow-up all matter. Something that appears successful in an animal model may behave very differently in a human being.
That concern also applies to biohacking.
Neil brings up well-known longevity personalities who experiment aggressively with diet, supplements, technology, testing, and other interventions. McCunney says the fundamental problem with experimenting on yourself is that you may not know whether something is effective, how much is safe, or what unintended consequences could appear years later.
The conversation then moves into longevity centers, which combine traditional preventive medicine with emerging interventions intended to improve healthspan and potentially extend life.
Some begin with established practices: cancer screenings, exercise, nutrition, weight management, and monitoring known risk factors.
Others push further into experimental territory involving stem cells, gene therapies, and off-label medications.
McCunney also explains an important difference between life expectancy and lifespan.
Life expectancy is a statistical average influenced by deaths from accidents, disease, childhood mortality, and countless other factors. Lifespan asks a different question: how long can a human being potentially live?
That distinction matters as more people live into their 90s and beyond.
McCunney says basic habits still matter tremendously: remaining physically active, staying socially connected, keeping the mind engaged, eating well, maintaining a healthy weight, and avoiding smoking. Genetics may become increasingly important among people who reach exceptionally advanced ages.
The discussion also touches on brain health, Alzheimer’s disease, AI, Neuralink, robotics, and whether future technology could eventually redefine what it means to grow old.
McCunney does not claim that humans are about to become immortal. His approach is more measured: the science is advancing quickly enough that ideas once dismissed as impossible